LITHIOFOR cpr ret 660 mg 250 pce
7680380610384
CH-38061
N05AN01
01.06.0.
1 / 3
google
Details
- Product number
- 3806101
- CPT
- -
- Packaging group
- 250
- Unit
- Tablette(n)
- Composition
- lithii sulfas anhydricus 660 mg corresp. lithium 12 mmol, hypromellosum, ammonio methacrylatis copolymerum B, magnesii stearas, excipiens pro compresso.
Articles (1)
Lithiofor, comprimés à libération prolongée
Tabletten
250
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
660.0 MG | Substance | WIZUS |
|
(N/A)
|
12.0 MMOL | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 61.95
Specialties list
Yes
Generic
No
SL addition date:
15/03/1976
Authorization holder
OM Pharma Suisse SA
1752 Villars-sur-Glâne
Authorization information
- Swissmedic authorization number
- 38061
- Drug name
- Lithiofor, comprimés à liberation prolongée
- Galenic form
- RETT
- ATC Code
- N05AN01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 17/08/1973
- Authorization expiration date
- 31/12/9999
- IT number
- 01.06.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- LITHIOFOR cpr ret 660 mg 250 pce
- Description (DE)
- LITHIOFOR Ret Tabl 660 mg 250 Stk
- Market launch
- 17/08/1973
- Narcotic (BTM)
- No